Endonovo Therapeutics, Inc.

ENDVOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$31875

P/E Ratio—

52W High$0.0003

52W Low$0.00005

Avg Volume724K

Open$0.00

Beta-8.45

Overview

Endonovo Therapeutics, Inc. (ENDV) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ENDV · as of Apr 17, 2023

Latest filing snapshot

+2+28.57%vs prior year

Endonovo Therapeutics, Inc. (ENDV) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+28.57%

Revenue / Employee

—

Net Income / Employee

$-241.8K

Market Cap

$0M

ENDV Employee Count

2011 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2023-04-17	2022-12-31	9	+2	+28.57%
2022-04-14	2021-12-31	7	-5	-41.67%
2021-04-13	2020-12-31	12	+2	+20.00%
2020-05-04	2019-12-31	10	+0	+0.00%
2019-04-15	2018-12-31	10	-5	-33.33%
2018-04-06	2017-12-31	15	+5	+50.00%
2017-04-17	2016-12-31	10	+0	+0.00%
2016-04-05	2015-12-31	10	+0	+0.00%
2015-04-03	2014-12-31	10	-7	-41.18%
2014-04-15	2013-12-31	17	+3	+21.43%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ITMC

Itoco Inc.

47$0M

GNLKQ

GeneLink, Inc.

14$0M

AMBS

Amarantus BioScience Holdings, Inc.

12$0M #4

ENDV

Endonovo Therapeutics, Inc.YOU

9$0M

AFFY

Affymax, Inc.

2$0M

CNBX

CNBX Pharmaceuticals Inc.

1$0M #7

BSSP

Baseline Productions, Inc.

N/A$0M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ENDV peer comparison

About ENDV employees

ENDV Employees · Headcount

Endonovo Therapeutics, Inc. (ENDV) employee data is sourced from the annual SEC 10-K filing. As of 2022, Endonovo Therapeutics, Inc. had 9 full-time employees globally. Full-time employees only. Global consolidated headcount.

Endonovo Therapeutics, Inc.'s workforce increased by 2 (28.57%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ENDV Employees · 5 questions

As of the latest SEC 10-K filing (2022), Endonovo Therapeutics, Inc. had 9 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Endonovo Therapeutics, Inc. employee counthow many employees does Endonovo Therapeutics, Inc. haveENDV total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-04-17